Building Resilient Families
A Multi-Component Intervention to Strengthen Families With Adverse Childhood Experiences (ACEs)
1 other identifier
interventional
340
1 country
1
Brief Summary
Prior research suggests that it is possible to improve health outcomes in children with ACEs through multi-component interventions. The challenge for most communities is that health and education systems are fragmented and fail to accommodate families based upon different levels of need. This study utilizes cross-sectoral partnerships to mobilize three vectors (pediatricians, community health workers and parenting educators) to optimize the delivery of vital information and resources to a diverse population of families with ACEs. All vectors are trained in an evidence-informed curriculum to strengthen families and build youth resilience. The study design is a randomized controlled trial of 340 families of children between the ages of 3 to 11 who are generally healthy and have recently seen a pediatrician for a well-child visit. To evaluate the efficacy of this intervention, pediatric patients are invited to participate in repeat evaluations within 2 weeks, 3 months, 6 months, and 12 months after their well-child visit. The study will evaluate the following: 1) the association between Child-ACE scores and biomarkers of toxic stress at baseline in children age 3-11 years old; 2) whether the intervention reduces toxic stress and child health and psychosocial problems at follow-up for children with ACEs compared to usual well-child care for children with ACEs; and 3) the impact of mediating and moderating variables. These results will demonstrate that for families with ACEs the intervention will decrease toxic stress associated with ACEs, improve health outcomes, and reduce health disparities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
May 24, 2022
CompletedStudy Start
First participant enrolled
May 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
ExpectedOctober 29, 2025
October 1, 2025
3.9 years
May 19, 2022
October 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Child Allostatic Load Index
A composite measurement that combines biometric data, neuroendocrine and immune markers, and executive function to determine whether the intervention lowers physiologic stress for children with ACEs. Each group will be followed over one year and growth curves will be analyzed to compare change in physiologic stress between baseline and final follow-up.
Change between baseline and visit 4 (1-year post-enrollment)
Secondary Outcomes (1)
Pediatric Symptom Checklist (PSC)
Change between baseline and visit 4 (1-year post-enrollment)
Study Arms (3)
Three-Tier Model
EXPERIMENTAL130 children with ACEs who received well-child care by a trained provider will be enrolled in this group.
Comparison Group
NO INTERVENTION80 children without ACEs who received usual well-child care will be enrolled in this group.
Control Group
NO INTERVENTION130 children with ACEs who received usual well-child care will be enrolled in this group.
Interventions
Families in the intervention will be counseled by a pediatric provider about ACEs, resilience, stress management, and healthy relationships. Families will also be referred to community health workers and parenting educators.
Eligibility Criteria
You may qualify if:
- Ages 3-11
- Seen for a well-child visit at a participating pediatric clinic
You may not qualify if:
- \< 3 years or \>11 years of age
- Significant congenital medical problems
- Previous participation in parenting program (last 12 months)
- Sibling enrollment in current study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University
Loma Linda, California, 92354, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Ariane Marie-Mitchell, MD, PhD, MPH
Loma Linda University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The pediatric patients, their caregivers and teachers are blinded to arm type.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2022
First Posted
May 24, 2022
Study Start
May 24, 2022
Primary Completion
May 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
October 29, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share